1-2 of 2
Christelle M. Colin-Leitzinger
Close
Sort by
Journal Articles

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi, Christelle M. Colin-Leitzinger, Alexandria M. Shrewsbury, Hitomi Hosoya, Rebecca M. Gonzalez, Christina Copponex, Krista H. Kottra, Vanna Hovanky, Bita Sahaf, Sunita Patil, Aleksandr Lazaryan, Michael D. Jain, Aliyah Baluch, Olga V. Klinkova, Nelli Bejanyan, Rawan G. Faramand, Hany Elmariah, Farhad Khimani, Marco L. Davila, Asmita Mishra, Brandon J. Blue, Ariel F. Grajales-Cruz, Omar A. Castaneda Puglianini, Hien D. Liu, Taiga Nishihori, Ciara L. Freeman, Jason B. Brayer, Kenneth H. Shain, Rachid C. Baz, Frederick L. Locke, Melissa Alsina, Surbhi Sidana, Doris K. Hansen
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6109–6119.
https://doi.org/10.1182/bloodadvances.2022008320
Published: 2022
Includes: Supplemental data
Journal Articles

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma

Clinical Trials & Observations
Lauren C. Peres, Christelle M. Colin-Leitzinger, Mingxiang Teng, Julie Dutil, Raghunandan R. Alugubelli, Gabriel DeAvila, Jamie K. Teer, Dongliang Du, Qianxing Mo, Erin M. Siegel, Oliver A. Hampton, Melissa Alsina, Jason Brayer, Brandon Blue, Rachid Baz, Ariosto S. Silva, Taiga Nishihori, Kenneth H. Shain, Nancy Gillis
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3767–3778.
https://doi.org/10.1182/bloodadvances.2021006652
Published: 2022
Includes: Supplemental data